Knauf Insulation Earns First asthma & allergy friendly® Certification for Fiberglass Acoustic Panel

2022-06-10 20:53:34 By : Mr. Charles Zeng

SHELBYVILLE, Ind. , May 24, 2022 /PRNewswire/ -- Knauf Insulation, Inc., has earned the asthma & allergy friendly® Certification for its Performance+™ Acoustic Panel.

The asthma & allergy friendly® Certification Program, an independent program established in the United States by the Asthma and Allergy Foundation of America (AAFA) and Allergy Standards Limited (ASL), helps consumers identify products more suitable for people with asthma and allergies by developing scientific standards that products must meet. The program performs physical and chemical testing on products to ensure they reduce allergen exposure and limit pollutants in the indoor environment. The Certification Mark is awarded only to those products that meet the scientific criteria.

"This asthma & allergy friendly® certification is evidence of Knauf's commitment to providing high quality products that can improve indoor air quality and help create healthier home environments," says Nathan Walker , Knauf Insulation's Senior Vice President of Customer Experience, Innovation, and Sales.

Knauf's Performance+ products are designed for sound control, low dust and superior fire rating. To meet the asthma & allergy friendly® certification standards, the Knauf Performance+ Acoustic Panel was tested for low emission of volatile organic compounds (VOCs). In relation to material science, the panel was assessed for chemicals and allergenic properties. As the only formaldehyde-free fiberglass acoustic panel on the market, homeowners can easily add the Knauf Insulation panels to spaces where sound and comfort matter most like nurseries, home offices or theater rooms.

May is National Asthma and Allergy Awareness Month, a month dedicated to building understanding, educating, and advocating for the 65 million Americans who live with asthma and allergies. Optimizing indoor air quality is critical, as indoor air has been found to be up to five times more polluted than outdoor air, according to the EPA.

"At this time of increased focus on healthy indoor air and wellness at home it is vital that all product claims are based on good science. We congratulate Knauf Insulation on their certification, which involved a robust scientific verification and inspection of their product, particularly on how it relates to low VOCs and constituent materials," said Dr. John McKeon , CEO of Allergy Standards Ltd.

About the asthma & allergy friendly® Certification Program

The asthma & allergy friendly® Certification Program is a unique, groundbreaking collaboration between the Asthma and Allergy Foundation of America and Allergy Standards Limited. This program helps people make informed purchases for a #healthierhome. The program tests household products against strict standards. Products passing these tests earn the CERTIFIED asthma & allergy friendly® mark. Certified products include air cleaners, bedding, cleaning products, flooring, paints, vacuum cleaners, washing machines, and more. Visit aafa.org/certified for more information.

About Knauf Insulation North America

Knauf Insulation North American is part of Knauf Group, a family-owned global manufacturer of building materials based in Iphofen, Germany . Knauf leverages the expertise of over 35,000 employees across 250 production facilities in 86 countries to generate revenue in excess of $12 Billion . In North America , Knauf Insulation is a leading manufacturer of thermal and acoustical fiberglass insulation for residential, commercial, industrial, OEM and metal building applications. Knauf's mission is to challenge conventional thinking and create innovative solutions that shape the way we live and build in the future, with care for the people who make them, the people who use them and the world we all depend on.

For more information, visit www.knaufnorthamerica.com

Media Contacts: Linda McGovern 847-287-9805 Linda.Mcgovern@knauf.com

Amanda Pollard 312-914-4417 apollard@tellyourstoryinc.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/knauf-insulation-earns-first-asthma--allergy-friendly-certification-for-fiberglass-acoustic-panel-301554399.html

The FDA recommended Blueprint Medicines change the ultimate goal of a midstage study, leading BPMC stock to crumble Thursday.

A group of pharmaceutical stocks are climbing as they pivot their diabetes drugs to a more holistic approach to obesity treatment. A potential multibillion-dollar market beckons them.

GBT said Friday its sickle cell treatment, Oxbryta, helped lower markers of the disorder in a real-world study, but GBT stock yo-yoed.

Researchers say Ayurvedic medicines help control blood sugar levels in patients

It's over two years since the official beginning of the COVID-19 pandemic—and many people have experienced scary virus symptoms. "If you have long COVID symptoms, you should seek care," says Devang Sanghavi, MD. "As we have seen in a lot of these surveys and studies about post-COVID syndrome is that usually this condition doesn't come with just one symptom—there's a cluster of symptoms. Don't label it as post-COVID right away. You want to make sure that it's not something new, and then you obvio

Strawberries aren't the only foods that can be contaminated with hepatitis A. Here's how to protect yourself.

The findings come from a study of nearly 500,000 participants

Children whose mothers had coronavirus infections during pregnancy were more likely to be diagnosed with neurodevelopmental problems, a study finds.

Diabetes may increase the risk of long COVID, new analyses of seven previous studies suggest. Researchers reviewed studies that tracked people for at least four weeks after COVID-19 recovery to see which individuals developed persistent symptoms associated with long COVID such as brain fog, skin conditions, depression, and shortness of breath. In three of the studies, people with diabetes were up to four times more likely to develop long COVID compared to people without diabetes, according to a presentation https://eppro02.ativ.me/web/page.php?page=IntHtml&project=ADA22&id=1683 on Sunday at the annual Scientific Sessions of the American Diabetes Association.

A small clinical trial of drug dostarlimab, a monoclonal antibody, got rid of rectal cancer in all patients. More about immunotherapy for cancer treatment.

Sepsis begins with infection by bacteria or a virus. This panoramic ilustration inside a blood vessel shows rod-shaped bacteria, red blood cells and immune cells called leukocytes. Kateryna Kon/Science Photo Library via Getty ImagesCan an otherwise healthy young woman die from what starts out as something akin to a common cold? The answer is, shockingly, yes, when certain telltale signs of a more serious problem go undetected. Though many people haven’t even heard of it, sepsis – the body’s extr

The ongoing outbreak is the largest to occur outside of the countries where the virus usually circulatesBy Kevin LoriaThe world is currently experiencing the largest outbreak of the disease known...

Troopers said the teenager was walking along the highway when the Georgia woman drove off the road, struck her and then continued on.

Dr. Bindi Naik-Mathuria, a pediatric trauma surgeon at Baylor College of Medicine, told Yahoo News that injuries from an AR-15 style rifle are “almost unsurvivable, essentially,” because of the significant damage the bullets cause to the victims.

Participants in small experimental cancer drug trial see tumors vanish

STORY: A gunman opened fire on his co-workers at a manufacturing facility in northern Maryland on Thursday, killing multiple people before being taken into custody after a shootout with police. Washington County Sheriff Douglas Mullendore did not immediately identify the 23-year-old assailant, but told a news conference a state trooper stopped him as he was trying to flee. “The suspect had fled the scene prior to law enforcement’s arrival. The vehicle was encountered by the Maryland state police on Mapleville Road route 66 on the area of Mount Etna Road. The suspect and the trooper exchanged fire, both subjects were injured.” The sheriff said they were both taken to a local hospital for treatment of gunshot wounds. He added the shooter used a semi-automatic pistol handgun but would not give details on the possible motives behind the attack. “At this time, I can confirm that all the victims and the suspects were current employees of the Colombia Machine Incorporated.” A company spokesperson said they were cooperating with authorities on the investigation and declined to comment further.

Getting blood drawn doesn't exactly top anyone's list of most-fun activities. But a new blood test that measures levels of a toxic compound produced by popular foods we eat can help predict the future of your heart health—and ultimately help lower your risk of heart attack, stroke, and premature death.Trimethylamine N-oxide (TMAO) is a toxic compound that's produced by the interaction between certain foods and gut microbes during digestion. "TMAO is not present in food," explains Purna Kashyap,

Dementia is a brain disorder that affects memory, social skills and thinking abilities. According to the World Health Organization, "Currently more than 55 million people live with dementia worldwide, and there are nearly 10 million new cases every year." Symptoms can become so severe that daily life is affected and some patients will need caretakers. In addition, dementia can be deadly. The National Library of Medicine states, "In 2017, a total of 261,914 deaths attributable to dementia as an u

“Her heart can’t take the stress and trauma of this past week,” the fourth grader's mom wrote.

Rhode Island's first probable case of monkeypox has been detected in a Providence County man in his thirties, health department officials said Thursday.